-
Harvest Healthcare Leaders Income ETF (HHL $6.83)
- $6.83 P/E (TTM): 23.48X Cap: $1.63B
- View HHL Profile
- View Questions on HHL
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Intuitive Surgical Inc. (ISRG $454.21)
- $454.21 P/E (TTM): 55.62X Cap: $162.12B
- View ISRG Profile
- View Questions on ISRG
-
AbbVie Inc. (ABBV $206.20)
- $206.20 P/E (TTM): 87.54X Cap: $365.42B
- View ABBV Profile
- View Questions on ABBV
-
Johnson & Johnson (JNJ $225.12)
- $225.12 P/E (TTM): 20.6X Cap: $546.89B
- View JNJ Profile
- View Questions on JNJ
-
Eli Lilly and Company (LLY $958.79)
- $958.79 P/E (TTM): 41.98X Cap: $907.20B
- View LLY Profile
- View Questions on LLY
-
Merck & Company Inc. (MRK $113.35)
- $113.35 P/E (TTM): 15.41X Cap: $277.17B
- View MRK Profile
- View Questions on MRK
-
Harvest Healthcare Leaders Income ETF (HHL $6.83)
- $6.83 P/E (TTM): 23.48X Cap: $1.63B
- View HHL Profile
- View Questions on HHL
-
Vanguard Health Care ETF (VHT $271.34)
- $271.34 P/E (TTM): 24.74X Cap: $17.75B
- View VHT Profile
- View Questions on VHT
-
Teladoc Health Inc. (TDOC $6.63)
- $6.63 Cap: $1.16B
- View TDOC Profile
- View Questions on TDOC
Q: According to portfolio analytics, I'm seriously underweight in Healthcare, something which I should probably correct. Any of these names herein stick out as great buys in healthcare. US or CAD, no difference to me. Thank you.
-
Harvest Healthcare Leaders Income ETF (HHL $6.83)
- $6.83 P/E (TTM): 23.48X Cap: $1.63B
- View HHL Profile
- View Questions on HHL
-
Evolve Global Healthcare Enhanced Yield Fund (LIFE $16.83)
- $16.83 P/E (TTM): 16.07X Cap: $246M
- View LIFE Profile
- View Questions on LIFE
Q: I am thinking of adding one of these 2 beaten down health related ETF's to my holdings. I wonder if you can tell me if you feel either or both are at risk of further decline due to Trumps RX plan, and/or their exposure to the US healthcare system which seems to be under attack by this administration?
Do you have a preference for one over the other, or do you have another name in this space that you like, and how safe do you feel the dividend is for each of them?
I am looking for a steady reliable yield and prefer ones that trade in Canada. Thank you.
Do you have a preference for one over the other, or do you have another name in this space that you like, and how safe do you feel the dividend is for each of them?
I am looking for a steady reliable yield and prefer ones that trade in Canada. Thank you.
-
Harvest Healthcare Leaders Income ETF (HHL $6.83)
- $6.83 P/E (TTM): 23.48X Cap: $1.63B
- View HHL Profile
- View Questions on HHL
Q: Retired, dividend-income investor. Long term holder of HHL with a full position. It is my proxy for the health care sector.
Looking at your "total return" chart (capital gain + distribution) over multiple time frames, it appears to me we may be approaching some significant support in the $6,50 to $6.60 area.
Would you agree that the risk-reward ratio is swinging in favor of adding additional funds? Or, do we need to continue to sit on our hands and wait for a change in USA Healthcare Gov't leadership?
Happy to continue to just sit......Steve
Looking at your "total return" chart (capital gain + distribution) over multiple time frames, it appears to me we may be approaching some significant support in the $6,50 to $6.60 area.
Would you agree that the risk-reward ratio is swinging in favor of adding additional funds? Or, do we need to continue to sit on our hands and wait for a change in USA Healthcare Gov't leadership?
Happy to continue to just sit......Steve
Insiders
Share Information
News and Media